Literature DB >> 10357116

Secondary amyloidosis has decreased in patients with inflammatory joint disease in Finland.

K Laiho1, S Tiitinen, K Kaarela, H Helin, H Isomäki.   

Abstract

We studied whether the high incidence of secondary amyloidosis (SA) is a consistent finding in patients with inflammatory joint disease. A total of 4508 biopsies of patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis were studied at the Rheumatism Foundation Hospital during 1987-1997. The results show that the annual number of findings of SA was reduced from 68 to less than 10. We suggest that a change in medication towards more frequent use of cytostatic agents is the reason for the reduction in incidence of SA.

Entities:  

Mesh：

Year:  1999        PMID： 10357116     DOI： 10.1007/s100670050068

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   2.980


  12 in total

1.  Where has secondary amyloid gone?

Authors:  B P Hazenberg; M H van Rijswijk
Journal:  Ann Rheum Dis       Date:  2000-08       Impact factor: 19.103

Review 2.  Systemic amyloidosis: a challenge for the rheumatologist.

Authors:  Federico Perfetto; Alberto Moggi-Pignone; Riccardo Livi; Alessio Tempestini; Franco Bergesio; Marco Matucci-Cerinic
Journal:  Nat Rev Rheumatol       Date:  2010-06-08       Impact factor: 20.543

3.  [Amyloid diagnostics in rheumatic diseases].

Authors:  C Röcken; J Ernst
Journal:  Pathologe       Date:  2006-11       Impact factor: 1.011

Review 4.  From bench to bedside and back again: translational research in autoinflammation.

Authors:  Dirk Holzinger; Christoph Kessel; Alessia Omenetti; Marco Gattorno
Journal:  Nat Rev Rheumatol       Date:  2015-06-16       Impact factor: 20.543

5.  Oral involvement in a case of AA amyloidosis: a case report.

Authors:  M Inanç Cengiz; Hom-Lay Wang; Levent Yıldız
Journal:  J Med Case Rep       Date:  2010-06-30

Review 6.  Pathophysiology and treatment of systemic amyloidosis.

Authors:  Julian D Gillmore; Philip N Hawkins
Journal:  Nat Rev Nephrol       Date:  2013-08-27       Impact factor: 28.314

7.  The prevalence of subclinical amyloidosis in Polish patients with rheumatoid arthritis.

Authors:  Piotr Wiland; Renata Wojtala; John Goodacre; Jacek Szechinski
Journal:  Clin Rheumatol       Date:  2004-02-26       Impact factor: 2.980

Review 8.  Prognostic factors in juvenile idiopathic arthritis.

Authors:  A M Prieur; G Chèdeville
Journal:  Curr Rheumatol Rep       Date:  2001-10       Impact factor: 4.686

9.  Comparison of amyloid deposition in human kidney biopsies as predictor of poor patient outcome.

Authors:  Ekaterina Castano; Matthew B Palmer; Christine Vigneault; Randy Luciano; Serena Wong; Gilbert Moeckel
Journal:  BMC Nephrol       Date:  2015-04-29       Impact factor: 2.388

Review 10.  Monoclonal antibodies in rheumatoid arthritis: comparative effectiveness of tocilizumab with tumor necrosis factor inhibitors.

Authors:  Toshio Tanaka; Yoshihiro Hishitani; Atsushi Ogata
Journal:  Biologics       Date:  2014-04-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.